CN103582700A - 新的蛋白质纯化方法 - Google Patents
新的蛋白质纯化方法 Download PDFInfo
- Publication number
- CN103582700A CN103582700A CN201280024868.4A CN201280024868A CN103582700A CN 103582700 A CN103582700 A CN 103582700A CN 201280024868 A CN201280024868 A CN 201280024868A CN 103582700 A CN103582700 A CN 103582700A
- Authority
- CN
- China
- Prior art keywords
- aqueous solution
- tensio
- active agent
- nonsurfactant
- nonionics
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/02—Recovery or purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14311—Parvovirus, e.g. minute virus of mice
- C12N2750/14351—Methods of production or purification of viral material
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Water Supply & Treatment (AREA)
- Analytical Chemistry (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
抗体 | 表面活性剂 | LRV |
抗-VEGF | 0ppm聚山梨醇20 | 4.05 |
抗-VEGF | 100ppm聚山梨醇20 | 4.55 |
抗-VEGF | 1000ppm聚山梨醇20 | 4.37 |
抗-PDL1 | 0ppm聚山梨醇20 | 4.30 |
抗-PDL1 | 100ppm聚山梨醇20 | 4.59 |
抗-PDL1 | 1000ppm聚山梨醇20 | 4.67 |
Claims (78)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161467897P | 2011-03-25 | 2011-03-25 | |
US61/467,897 | 2011-03-25 | ||
PCT/US2012/030265 WO2012134987A1 (en) | 2011-03-25 | 2012-03-23 | Novel protein purification methods |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103582700A true CN103582700A (zh) | 2014-02-12 |
CN103582700B CN103582700B (zh) | 2016-08-17 |
Family
ID=46931857
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201280024868.4A Active CN103582700B (zh) | 2011-03-25 | 2012-03-23 | 新的蛋白质纯化方法 |
Country Status (18)
Country | Link |
---|---|
US (1) | US10906934B2 (zh) |
EP (1) | EP2697369B1 (zh) |
KR (1) | KR20140022845A (zh) |
CN (1) | CN103582700B (zh) |
AU (1) | AU2012237026A1 (zh) |
BR (1) | BR112013024521A2 (zh) |
CA (1) | CA2830640A1 (zh) |
ES (1) | ES2685079T3 (zh) |
HK (1) | HK1194434A1 (zh) |
HR (1) | HRP20181357T1 (zh) |
IL (1) | IL228438A0 (zh) |
MX (1) | MX2013010737A (zh) |
PL (1) | PL2697369T3 (zh) |
RU (1) | RU2013147609A (zh) |
SG (1) | SG193564A1 (zh) |
SI (1) | SI2697369T1 (zh) |
TR (1) | TR201810703T4 (zh) |
WO (1) | WO2012134987A1 (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106661565A (zh) * | 2014-08-27 | 2017-05-10 | 合同酒精株式会社 | 乳糖酶溶液及使用其的乳 |
CN112189015A (zh) * | 2018-03-27 | 2021-01-05 | 赛诺菲 | 用于纯化重组蛋白的完全流穿过程 |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20090074040A (ko) | 2006-09-13 | 2009-07-03 | 아보트 러보러터리즈 | 세포 배양의 개선 |
US8911964B2 (en) | 2006-09-13 | 2014-12-16 | Abbvie Inc. | Fed-batch method of making human anti-TNF-alpha antibody |
SG10201702922VA (en) | 2008-10-20 | 2017-06-29 | Abbvie Inc | Isolation and purification of antibodies using protein a affinity chromatography |
SG10201702951RA (en) | 2008-10-20 | 2017-06-29 | Abbvie Inc | Viral inactivation during purification of antibodies |
SI2697369T1 (sl) | 2011-03-25 | 2018-10-30 | F. Hoffmann-La Roche Ag | Novi postopki čiščenja beljakovin |
US8933009B2 (en) | 2013-03-12 | 2015-01-13 | Ecolab Usa Inc. | Surfactant blends for cleaning filtration membranes |
MX2016006167A (es) | 2013-11-15 | 2016-08-08 | Genentech Inc | Metodos para la inactivacion viral usando detergentes ecologico. |
EP3371302B1 (en) * | 2015-11-05 | 2024-01-03 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Method for the separation of virus compositions including depletion and purification thereof |
SG11201911877RA (en) | 2017-06-12 | 2020-01-30 | Asahi Kasei Medical Co Ltd | Method for filtering protein-containing liquid |
JP7074845B2 (ja) | 2017-09-29 | 2022-05-24 | エコラボ ユーエスエー インコーポレイティド | プロセス膜洗浄における延長界面活性剤の使用 |
AU2019222696B2 (en) | 2018-02-14 | 2024-02-29 | Ecolab Usa Inc. | Compositions and methods for the reduction of biofilm and spores from membranes |
BR112021021972A2 (pt) | 2019-05-03 | 2021-12-21 | Hoffmann La Roche | Métodos de redução de uma taxa de atividade de hidrólise enzimática, de redução do nível de uma ou mais enzimas hidrolíticas e de redução da degradação de um polissorbato, composições farmacêuticas e composições de porção de anticorpo formulada |
US20220411467A1 (en) * | 2019-12-12 | 2022-12-29 | Nutrition & Biosciences Usa 1, Llc | Protein bioprocess |
UY39318A (es) * | 2020-07-10 | 2022-02-25 | Grifols Worldwide Operations Ltd | Procedimiento para obtener una composicion que comprende inmunoglobulina m derivada de plasma humano |
BR112023000584A2 (pt) * | 2020-07-15 | 2023-03-28 | Nutrition & Biosciences Usa 1 Llc | Bioprocesso com depósito de impurezas reduzido nas superfícies |
CA3198684A1 (en) | 2020-10-30 | 2022-05-05 | Genentech, Inc. | Purification platforms for obtaining pharmaceutical compositions having a reduced hydrolytic enzyme activity rate |
CN115779683B (zh) * | 2022-12-16 | 2024-03-22 | 康日百奥生物科技(苏州)有限公司 | 除病毒过滤方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5096637A (en) * | 1990-05-10 | 1992-03-17 | Millipore Corporation | Membrane, process and system for isolating virus from solution |
CN101155915A (zh) * | 2005-04-11 | 2008-04-02 | 克鲁塞尔荷兰公司 | 利用超滤进行病毒纯化 |
CN101262884A (zh) * | 2005-01-28 | 2008-09-10 | 艾兰制药国际有限公司 | 抗Aβ抗体制剂 |
CN101500951A (zh) * | 2006-08-09 | 2009-08-05 | 塞福斯贸易有限公司 | 阻垢方法 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US4618533A (en) | 1984-11-30 | 1986-10-21 | Millipore Corporation | Porous membrane having hydrophilic surface and process |
DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
EP0617706B1 (en) | 1991-11-25 | 2001-10-17 | Enzon, Inc. | Multivalent antigen-binding proteins |
ATE198996T1 (de) | 1994-07-28 | 2001-02-15 | Millipore Corp | Porösesverbundmembran und verfahren |
US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
US5888401A (en) | 1996-09-16 | 1999-03-30 | Union Camp Corporation | Method and apparatus for reducing membrane fouling |
US7365166B2 (en) * | 1997-04-07 | 2008-04-29 | Genentech, Inc. | Anti-VEGF antibodies |
US6096872A (en) | 1997-10-14 | 2000-08-01 | Ortho Diagnostic Systems, Inc. | Viral clearance process |
AU2001278716A1 (en) * | 2000-08-10 | 2002-02-25 | Chugai Seiyaku Kabushiki Kaisha | Method of inhibiting antibody-containing solution from coagulating or becoming turbid |
EP1441589B1 (en) | 2001-11-08 | 2012-05-09 | Abbott Biotherapeutics Corp. | Stable liquid pharmaceutical formulation of igg antibodies |
US7118675B2 (en) | 2002-02-04 | 2006-10-10 | Millipore Corporation | Process for removing protein aggregates and virus from a protein solution |
SI3483183T1 (sl) * | 2002-03-01 | 2021-08-31 | Immunomedics, Inc. | Imunokonjugat ki obsega humanizirana RS7 protitelesa |
AU2003239959A1 (en) * | 2002-06-14 | 2003-12-31 | Centocor, Inc. | Use of a clathrate modifier to promote passage of proteins during nanofiltration |
CA2490423A1 (en) * | 2002-06-21 | 2003-12-31 | Biogen Idec Inc. | Buffered formulations for concentrating antibodies and methods of use thereof |
AU2003268210A1 (en) * | 2002-08-28 | 2004-03-19 | Introgen Therapeutics Inc. | Chromatographic methods for adenovirus purification |
WO2005054275A2 (en) | 2003-12-01 | 2005-06-16 | Novo Nordisk Health Care Ag | Nanofiltration of factor vii solutions to remove virus |
AU2005229674B2 (en) | 2004-11-18 | 2010-11-04 | Kedrion Melville Inc. | Low concentration solvent/detergent process of immuneglobulin with pre-treatment |
US8741600B2 (en) | 2007-06-19 | 2014-06-03 | Asahi Kasei Kabushiki Kaisha | Method for separation of immunoglobulin monomers |
JP5755136B2 (ja) * | 2009-03-27 | 2015-07-29 | 旭化成メディカル株式会社 | 高濃度モノクローナル抗体溶液中のウイルス除去方法 |
KR20190018041A (ko) | 2009-08-06 | 2019-02-20 | 제넨테크, 인크. | 단백질 정제 시의 바이러스 제거의 개선방법 |
SI2697369T1 (sl) | 2011-03-25 | 2018-10-30 | F. Hoffmann-La Roche Ag | Novi postopki čiščenja beljakovin |
-
2012
- 2012-03-23 SI SI201231366T patent/SI2697369T1/sl unknown
- 2012-03-23 SG SG2013070909A patent/SG193564A1/en unknown
- 2012-03-23 MX MX2013010737A patent/MX2013010737A/es unknown
- 2012-03-23 WO PCT/US2012/030265 patent/WO2012134987A1/en active Application Filing
- 2012-03-23 AU AU2012237026A patent/AU2012237026A1/en not_active Abandoned
- 2012-03-23 TR TR2018/10703T patent/TR201810703T4/tr unknown
- 2012-03-23 CA CA2830640A patent/CA2830640A1/en not_active Abandoned
- 2012-03-23 PL PL12763521T patent/PL2697369T3/pl unknown
- 2012-03-23 EP EP12763521.7A patent/EP2697369B1/en not_active Revoked
- 2012-03-23 BR BR112013024521A patent/BR112013024521A2/pt not_active IP Right Cessation
- 2012-03-23 US US14/007,610 patent/US10906934B2/en active Active
- 2012-03-23 KR KR1020137027779A patent/KR20140022845A/ko not_active Application Discontinuation
- 2012-03-23 RU RU2013147609/10A patent/RU2013147609A/ru not_active Application Discontinuation
- 2012-03-23 ES ES12763521.7T patent/ES2685079T3/es active Active
- 2012-03-23 CN CN201280024868.4A patent/CN103582700B/zh active Active
-
2013
- 2013-09-15 IL IL228438A patent/IL228438A0/en unknown
-
2014
- 2014-08-04 HK HK14107970.3A patent/HK1194434A1/zh unknown
-
2018
- 2018-08-24 HR HRP20181357TT patent/HRP20181357T1/hr unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5096637A (en) * | 1990-05-10 | 1992-03-17 | Millipore Corporation | Membrane, process and system for isolating virus from solution |
CN101262884A (zh) * | 2005-01-28 | 2008-09-10 | 艾兰制药国际有限公司 | 抗Aβ抗体制剂 |
CN101155915A (zh) * | 2005-04-11 | 2008-04-02 | 克鲁塞尔荷兰公司 | 利用超滤进行病毒纯化 |
CN101500951A (zh) * | 2006-08-09 | 2009-08-05 | 塞福斯贸易有限公司 | 阻垢方法 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106661565A (zh) * | 2014-08-27 | 2017-05-10 | 合同酒精株式会社 | 乳糖酶溶液及使用其的乳 |
CN106661565B (zh) * | 2014-08-27 | 2020-04-21 | 合同酒精株式会社 | 乳糖酶溶液及使用其的乳 |
CN112189015A (zh) * | 2018-03-27 | 2021-01-05 | 赛诺菲 | 用于纯化重组蛋白的完全流穿过程 |
Also Published As
Publication number | Publication date |
---|---|
TR201810703T4 (tr) | 2018-08-27 |
PL2697369T3 (pl) | 2018-12-31 |
KR20140022845A (ko) | 2014-02-25 |
SG193564A1 (en) | 2013-10-30 |
EP2697369A4 (en) | 2015-01-21 |
ES2685079T3 (es) | 2018-10-05 |
CN103582700B (zh) | 2016-08-17 |
HRP20181357T1 (hr) | 2018-10-19 |
RU2013147609A (ru) | 2015-04-27 |
SI2697369T1 (sl) | 2018-10-30 |
IL228438A0 (en) | 2013-12-31 |
EP2697369B1 (en) | 2018-06-27 |
WO2012134987A1 (en) | 2012-10-04 |
MX2013010737A (es) | 2014-03-12 |
BR112013024521A2 (pt) | 2019-09-24 |
AU2012237026A1 (en) | 2013-10-24 |
US10906934B2 (en) | 2021-02-02 |
EP2697369A1 (en) | 2014-02-19 |
US20140309403A1 (en) | 2014-10-16 |
NZ615579A (en) | 2016-09-30 |
HK1194434A1 (zh) | 2014-10-17 |
CA2830640A1 (en) | 2012-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103582700A (zh) | 新的蛋白质纯化方法 | |
US9890205B2 (en) | Chromatographic purification of immunoglobulin G preparations with particles having multimodal functionalities | |
CA2666607C (en) | Method of isolating biomacromolecules using low ph and divalent cations | |
AU2012309202B2 (en) | Plasma protein fractionation by sequential polyacid precipitation | |
KR20150113027A (ko) | 티오-헤테로시클릭 양이온들로 처리에 의한 단백질 제제 내의 응집체 레벨 감소를 위한 방법 | |
AU2009236653B2 (en) | Method of isolating biomacromolecules using polyalkylene glycol and transition metals | |
NZ615579B2 (en) | Novel protein purification methods | |
CN112805293A (zh) | 免去层析的抗体纯化方法 | |
JP6672293B2 (ja) | 改善された製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Owner name: F. HOFFMANN-LA ROCHE AG Free format text: FORMER OWNER: GENENTECH, INC. (US) 460 POINT SAN BRUNO BLVD, SOUTH SAN FRANCISCO, CA, 94080 Effective date: 20140110 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20140110 Address after: Basel, Switzerland Applicant after: F. HOFFMANN-LA ROCHE AG Address before: California, USA Applicant before: GENENTECH, Inc. |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1194434 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1194434 Country of ref document: HK |